Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…
Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History
SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
SOPHiA GENETICS Launches MSK-IMPACT powered with SOPHiA DDM at AMP 2024
Launch of new application enables global access to highly recognized solid tumor…
Baylor Genetics Wins BioTech Breakthrough Award
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic…